Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis
Clinical trial NCT00744016 · COMPLETED
Trial details
- NCT number
- NCT00744016
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2007-05-01
- Enrollment
- 305
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.